BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mediani L, Gibellini F, Bertacchini J, Frasson C, Bosco R, Accordi B, Basso G, Bonora M, Calabrò ML, Mattiolo A, Sgarbi G, Baracca A, Pinton P, Riva G, Rampazzo E, Petrizza L, Prodi L, Milani D, Luppi M, Potenza L, De Pol A, Cocco L, Capitani S, Marmiroli S. Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling. Oncotarget 2016;7:5521-37. [PMID: 26575168 DOI: 10.18632/oncotarget.6315] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Rigotto G, Montini B, Mattiolo A, Lazzari N, Piano MA, Remondini D, Marmiroli S, Bertacchini J, Chieco-Bianchi L, Calabrò ML. Mechanisms Involved in the Promoting Activity of Fibroblasts in HTLV-1-Mediated Lymphomagenesis: Insights into the Plasticity of Lymphomatous Cells. Int J Mol Sci 2021;22:10562. [PMID: 34638901 DOI: 10.3390/ijms221910562] [Reference Citation Analysis]
2 Oishi N, Hundal T, Phillips JL, Dasari S, Hu G, Viswanatha DS, He R, Mai M, Jacobs HK, Ahmed NH, Syrbu SI, Salama Y, Chapman JR, Vega F, Sidhu J, Bennani NN, Epstein AL, Medeiros JL, Clemens MW, Miranda RN, Feldman AL. Molecular profiling reveals a hypoxia signature in breast implant-associated anaplastic large cell lymphoma. Haematologica 2021;106:1714-24. [PMID: 32414854 DOI: 10.3324/haematol.2019.245860] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
3 Kirsch BJ, Chang SJ, Betenbaugh MJ, Le A. Non-Hodgkin Lymphoma Metabolism. Adv Exp Med Biol 2021;1311:103-16. [PMID: 34014537 DOI: 10.1007/978-3-030-65768-0_7] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Darici S, Zavatti M, Braglia L, Accordi B, Serafin V, Horne GA, Manzoli L, Palumbo C, Huang X, Jørgensen HG, Marmiroli S. Synergistic cytotoxicity of dual PI3K/mTOR and FLT3 inhibition in FLT3-ITD AML cells. Adv Biol Regul 2021;82:100830. [PMID: 34555701 DOI: 10.1016/j.jbior.2021.100830] [Reference Citation Analysis]
5 Chen XS, Li LY, Guan YD, Yang JM, Cheng Y. Anticancer strategies based on the metabolic profile of tumor cells: therapeutic targeting of the Warburg effect. Acta Pharmacol Sin 2016;37:1013-9. [PMID: 27374491 DOI: 10.1038/aps.2016.47] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 8.0] [Reference Citation Analysis]
6 Wong JP, Stuhlmiller TJ, Giffin LC, Lin C, Bigi R, Zhao J, Zhang W, Bravo Cruz AG, Park SI, Earp HS, Dittmer DP, Frye SV, Wang X, Johnson GL, Damania B. Kinome profiling of non-Hodgkin lymphoma identifies Tyro3 as a therapeutic target in primary effusion lymphoma. Proc Natl Acad Sci U S A 2019;116:16541-50. [PMID: 31346082 DOI: 10.1073/pnas.1903991116] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
7 Bertacchini J, Frasson C, Chiarini F, D'Avella D, Accordi B, Anselmi L, Barozzi P, Forghieri F, Luppi M, Martelli AM, Basso G, Najmaldin S, Khosravi A, Rahim F, Marmiroli S. Dual inhibition of PI3K/mTOR signaling in chemoresistant AML primary cells. Adv Biol Regul 2018;68:2-9. [PMID: 29576448 DOI: 10.1016/j.jbior.2018.03.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
8 Sola A, Bertacchini J, D'Avella D, Anselmi L, Maraldi T, Marmiroli S, Messori M. Development of solvent-casting particulate leaching (SCPL) polymer scaffolds as improved three-dimensional supports to mimic the bone marrow niche. Mater Sci Eng C Mater Biol Appl 2019;96:153-65. [PMID: 30606521 DOI: 10.1016/j.msec.2018.10.086] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 9.3] [Reference Citation Analysis]
9 Pi M, Kuang H, Yue C, Yang Q, Wu A, Li Y, Assaraf YG, Yang D, Wu S. Targeting metabolism to overcome cancer drug resistance: A promising therapeutic strategy for diffuse large B cell lymphoma. Drug Resistance Updates 2022;61:100822. [DOI: 10.1016/j.drup.2022.100822] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Xie Y, Shi X, Sheng K, Han G, Li W, Zhao Q, Jiang B, Feng J, Li J, Gu Y. PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia (Review). Mol Med Rep 2019;19:783-91. [PMID: 30535469 DOI: 10.3892/mmr.2018.9713] [Cited by in Crossref: 33] [Cited by in F6Publishing: 46] [Article Influence: 8.3] [Reference Citation Analysis]
11 Shimada K, Hayakawa F, Kiyoi H. Biology and management of primary effusion lymphoma. Blood 2018;132:1879-88. [DOI: 10.1182/blood-2018-03-791426] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 8.5] [Reference Citation Analysis]
12 Abdel-wahab AF, Mahmoud W, Al-harizy RM. Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy. Pharmacological Research 2019;150:104511. [DOI: 10.1016/j.phrs.2019.104511] [Cited by in Crossref: 80] [Cited by in F6Publishing: 89] [Article Influence: 26.7] [Reference Citation Analysis]
13 Kirsch BJ, Chang SJ, Le A. Non-Hodgkin Lymphoma Metabolism. Adv Exp Med Biol. 2018;1063:95-106. [PMID: 29946778 DOI: 10.1007/978-3-319-77736-8_7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
14 Mirabilii S, Ricciardi MR, Tafuri A. mTOR Regulation of Metabolism in Hematologic Malignancies. Cells 2020;9:E404. [PMID: 32053876 DOI: 10.3390/cells9020404] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Mosier JA, Schwager SC, Boyajian DA, Reinhart-King CA. Cancer cell metabolic plasticity in migration and metastasis. Clin Exp Metastasis 2021;38:343-59. [PMID: 34076787 DOI: 10.1007/s10585-021-10102-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Guerra F, Arbini AA, Moro L. Mitochondria and cancer chemoresistance. Biochimica et Biophysica Acta (BBA) - Bioenergetics 2017;1858:686-99. [DOI: 10.1016/j.bbabio.2017.01.012] [Cited by in Crossref: 134] [Cited by in F6Publishing: 126] [Article Influence: 26.8] [Reference Citation Analysis]
17 Broecker-Preuss M, Becher-Boveleth N, Bockisch A, Dührsen U, Müller S. Regulation of glucose uptake in lymphoma cell lines by c-MYC- and PI3K-dependent signaling pathways and impact of glycolytic pathways on cell viability. J Transl Med 2017;15:158. [PMID: 28724379 DOI: 10.1186/s12967-017-1258-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
18 Ruzzene M, Bertacchini J, Toker A, Marmiroli S. Cross-talk between the CK2 and AKT signaling pathways in cancer. Adv Biol Regul 2017;64:1-8. [PMID: 28373060 DOI: 10.1016/j.jbior.2017.03.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 6.4] [Reference Citation Analysis]
19 Shang Z, Feng H, Cui L, Wang W, Fu H. Propofol promotes apoptosis and suppresses the HOTAIR-mediated mTOR/p70S6K signaling pathway in melanoma cells. Oncol Lett 2018;15:630-4. [PMID: 29375720 DOI: 10.3892/ol.2017.7297] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
20 Hsieh I, Gopula B, Chou C, Wu H, Chang G, Wu W, Chang C, Chu P, Chen CS. Development of Novel Irreversible Pyruvate Kinase M2 Inhibitors. J Med Chem 2019;62:8497-510. [DOI: 10.1021/acs.jmedchem.9b00763] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
21 Piccaluga PP, Weber A, Ambrosio MR, Ahmed Y, Leoncini L. Epstein-Barr Virus-Induced Metabolic Rearrangements in Human B-Cell Lymphomas. Front Microbiol 2018;9:1233. [PMID: 29937761 DOI: 10.3389/fmicb.2018.01233] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
22 Dahl ES, Aird KM. Ataxia-Telangiectasia Mutated Modulation of Carbon Metabolism in Cancer. Front Oncol 2017;7:291. [PMID: 29238697 DOI: 10.3389/fonc.2017.00291] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
23 Oliveira GL, Coelho AR, Marques R, Oliveira PJ. Cancer cell metabolism: Rewiring the mitochondrial hub. Biochim Biophys Acta Mol Basis Dis 2021;1867:166016. [PMID: 33246010 DOI: 10.1016/j.bbadis.2020.166016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
24 Chen H, Sun Y, Yang Z, Yin S, Li Y, Tang M, Zhu J, Zhang F. Metabolic heterogeneity and immunocompetence of infiltrating immune cells in the breast cancer microenvironment (Review). Oncol Rep 2021;45:846-56. [PMID: 33650671 DOI: 10.3892/or.2021.7946] [Reference Citation Analysis]
25 Zhao Y, Yang L, He J, Yang H. STYK1 promotes Warburg effect through PI3K/AKT signaling and predicts a poor prognosis in nasopharyngeal carcinoma. Tumour Biol 2017;39:1010428317711644. [PMID: 28720063 DOI: 10.1177/1010428317711644] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]